Do pleiotropic effects of statins beyond lipid alterations exist in vivo? What are they and how do they differ between statins?
The inhibition of cellular proliferation, the restoration of endothelial activity, the inhibition of platelet reactivity, and an antioxidant potential are only a few examples of pleiotropic effects of statins. This review analyzes the current knowledge on the pleiotropic properties of this class of drugs and examines the relevant data that support the presence of these effects in vivo. The favorable outcome of major trials of statins has indicated that pleiotropic factors indeed play a role in cardiovascular protection. In addition, recent data indicate that many pleiotropic effects influence mechanisms that belong to the extravascular compartment, as well. Perhaps, some of these properties may eventually justify additional indications for statins and improve the treatment of other diseases, including inflammation and cancer.
Faggiotto
A
A
Institute of Pharmacological Sciences, University of Milan, Via Balzaretti, 9 I-20133, Milan, Italy.
Paoletti
R
R
D000924:Anticholesteremic Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D001161:Arteriosclerosis / Q000517:prevention & control; D001792:Blood Platelets / Q000502:physiology*; D004727:Endothelium / Q000502:physiology; D006801:Humans; D007249:Inflammation; D050356:Lipid Metabolism
D000924:Anticholesteremic Agents; D000975:Antioxidants